Last reviewed · How we verify
NCT06101810
The Efficacy of Treatments to Improve Self-esteem
NA trial testing COMET in Self Esteem in 70 participants. Currently enrolling.
1 August 2026
Quick facts
| Lead sponsor | GGZ Noord-Holland-Noord |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 1 November 2023 |
| Primary completion | 1 August 2026 |
| Estimated completion | 1 August 2026 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- COMET
- CBT — full drug profile →
Conditions studied
- Self Esteem — all drugs for Self Esteem →
Sponsor
GGZ Noord-Holland-Noord
Who can join
Adults 18 to 65, any sex, with Self Esteem. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to examine the effectivity of two self-esteem interventions (COMET (Korrelboom) and CBT (De Neef)) in a general psychiatric population. The main questions it aims to answer are: * is there a difference between the two interventions in effectiveness on increasing self-esteem? * is there a difference between the two interventions in effect on levels of anxiety, depression and general mental health? * are found effects on levels of anxiety, depression and general mental health associated with changes in self-esteem? * is the ability to use imagination a moderator for outcomes in both conditions? Participants are randomised over both conditions. At baseline (T0), end of treatment (T1) and follow-up at 6 months (T2) several outcome measures are conducted, such as RSES, DASS and MHC-SF.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06101810
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Self Esteem
Currently open trials in the same condition.
- NCT06964126 — Psycho-Social Effects of Gardening Activities in the Elderly · NA · recruiting
- NCT06785311 — Native Spirit: Significant Aim 3: Intervention · NA · recruiting
- NCT06693089 — Metacognitive Interpersonal Therapy Across Transdiagnostic Eating Disorders, Including Underweight · NA · recruiting
- NCT06608173 — Evaluation of radKIDS 2.0, a Multi-media Training Program for Elementary School Bullying and Abuse Prevention · NA · active not recruiting
- NCT06101225 — Effects of a Relaxation and Guided Imagery Intervention in School Context · NA · recruiting
Other GGZ Noord-Holland-Noord trials
Trials by the same sponsor.
- NCT06749041 — Nor)Clozapine Kinetics and Side Effects in Therapy Resistant Schizophrenia and the Optimal Sampling Time for Therapeutic · not yet recruiting
- NCT06617663 — Online Therapy Youth, Equivalent to Treatment As Usual? · NA · recruiting
- NCT05942495 — SFGT for Persistent Anxiety and Depression · NA · completed
- NCT05726812 — Plan My Life Together; a Group Training for Adolescents With ADHD · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06101810 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by GGZ Noord-Holland-Noord
- Last refreshed: 29 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06101810.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing